Small Business Funding Opportunities from the National Cancer Institute

Thursday, July 29, 2021 | 10 a.m.

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center provides funding, networking, and mentoring assistance to small businesses with early-stage innovative cancer technology projects. NCI SBIR Program Director, Dr. Xing-Jian Lou, and Program Manager, Dr. Reema Railkar, will present funding opportunities and commercialization resources for entrepreneurs and small businesses. This presentation is appropriate for both established and emerging entrepreneurs in small businesses or academia interested in moving life science technologies to patients and/or marketplace.

Registration closes Thursday, July 22nd.

NCI SBIR staff are available to meet with select researchers to discuss potential projects one-on-one following the event. Interested parties should submit specific aims and an executive summary by July 16th. Send email submissions to Ashley Francis at Afrancis@tmc.edu.

About TMC ACT
TMC ACT is the only cancer therapeutics accelerator building relationships with health care professionals leading the world’s best cancer treatment programs at the Texas Medical Center member hospitals. ACT is a Cancer Prevention and Research Institute of Texas (CPRIT) funded accelerator launched by the Texas Medical Center (TMC) in collaboration with the Gulf Coast Consortium (GCC) and the University of Texas Medical Branch (UTMB) to support Texas-based biotech entrepreneurs and researchers contemplating translations. Learn more about TMC ACT at https://www.tmc.edu/innovation/innovation-programs/tmc-act/.